论文部分内容阅读
随着结核病防治工作的开展,结核病的流行逐渐好转。但由于以往治疗不当,病情反复,一部分病例逐步转变成慢性复治病例(慢性空洞型或损毁型),病菌对原有一线药物高度耐药。这些病例是分散在社会上的传染源,是防治工作发展后期必然遇到的问题。利福平问世后,为此类病例的治疗开辟了一条新的途径。为探索利福平对此类病例的治疗效果,我们在门诊工作中进行了初步研究观察。一、病例来源:一、二线药物门诊治疗失败,痰菌持续阳性,未用过利福平者。共88例。二、治疗方法:随机分为三组,第一组
With the prevention and control of tuberculosis, the epidemic of tuberculosis gradually improves. However, due to improper treatment in the past, the disease repeatedly, some cases gradually transformed into chronic re-treatment cases (chronic cavity type or damaged type), the bacteria are highly resistant to the original first-line drugs. These cases are scattered sources of social contagion, is the inevitable problems encountered in the late development of prevention and control work. After the advent of rifampicin, the treatment of such cases has opened up a new avenue. To explore the therapeutic effect of rifampicin in such cases, we conducted a preliminary study in outpatient work. First, the source of the case: First and second-line drug out-patient treatment failed, sputum positive persistence, did not use risperidone. A total of 88 cases. Second, treatment: randomly divided into three groups, the first group